MedPath

The effect of computerised cognitive training on memory outcomes in older adults with documented cognitive decline.

Not Applicable
Withdrawn
Conditions
Secondary prevention of cognitive decline
Neurological - Dementias
Mental Health - Studies of normal psychology, cognitive function and behaviour
Registration Number
ACTRN12615001347550
Lead Sponsor
niversity of Sydney
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Withdrawn
Sex
All
Target Recruitment
86
Inclusion Criteria

Older adults (aged 60 years or older) with documented longitudinal cognitive decline unresponsive to intervention (not attributable by illness or new medication onset): those individuals who, over the course of at least 6-24 months and multiple neuropsychological assessments have had any memory-related test decline by at least 0.5SD of age-corrected norms despite routine clinic intervention. Memory tests administered by the clinics include: WMS-III Logical memory (I and II), the RAVLT and the Rey Complex Figure.

Exclusion Criteria

(1) history, diagnosis or treatment for dementia (of any aetiology); (2) current use of third-generation or tricyclic antidepressants; (3) history of stroke in last 12 months; (4) major neurological disorder requiring current treatment (epilepsy, Parkinson's disease); (5) major psychiatric disorder requiring current treatment (schizophrenia, bipolar disorder); (6) physical (sensory or motor) impairment that would limit training; (7) current undertaking of any other computerised cognitive training (CCT) program; (8) current alcohol dependence or abuse (defined as drinking over NHMRC guidelines); (9) definitive exclusion of possible undiagnosed major depression using the Geriatric Depression Scale (15-item score 10 or greater) or Hamilton Rating Scale for Depression (17-item score 12 or greater) i.e. if participants were found to have clinical depression scores at baseline measurement that were not previously diagnosed, these participants will be excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The RAVLT: Ability to learn new information, assessed by the Sum of Trials 1-5 (total learning).[all time points: baseline, 3 months, 6 months, 18 months];The RAVLT: Trials 7 score will measure delayed recall ability in memory. [Baseline, 3, 6, and 18 months]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath